Home > Healthcare > Pharmaceuticals > Finished Drug Form > Neutropenia Treatment Market

Neutropenia Treatment Market Trends

Report ID: GMI8441
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Neutropenia Treatment Market Trends

Rising utilization of chemotherapy, a widely employed therapy for diverse cancers, propelled by the increasing incidence of cancer is influencing the market growth. Chemotherapy frequently results in diminished neutrophil levels, necessitating efficient neutropenia treatments, thus stimulating market demand. However, the introduction of biosimilars has significantly impacted the market by offering a more cost-effective alternative to original brands. This has led to increased competition, pricing disparities, and potential market saturation, thereby hampering the overall market growth.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of neutropenia treatment was reached USD 14.5 billion in 2023 and is expected to register over 4.1% CAGR from 2024 to 2032, owing to the increasing prevalence of neutropenia, marked by abnormally low neutrophil levels which intensified the demand for neutropenia treatment worldwide.

Neutropenia treatment industry from the colony-stimulating factors segment is set to exceed USD 13 billion by 2032, due to its ability to stimulate the production of white blood cells, specifically neutrophils, which are crucial for combating infections.

North America neutropenia treatment industry is expected to record USD 7.4 billion by 2032 due to increasing cancer prevalence, demand for disease-specific treatment, robust healthcare spending, well-established infrastructure, and the presence of key market players in the region.

Biocon Biologics Inc., Cellerant Therapeutics, Coherus BioSciences, Inc., CuraTeQ Biologics Pvt. Ltd., Evive Biotech, Kyowa Kirin Co., Ltd., Pfizer Inc., Sandoz Inc., Spectrum Pharmaceuticals, and Teva Pharmaceutical Industries Ltd. are some of the major neutropenia treatment companies worldwide.